CAD 1.96
(0.51%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.44 CAD | -144.44% |
2022 | -0.18 CAD | 68.42% |
2021 | -0.57 CAD | 17.39% |
2020 | -0.69 CAD | -27.78% |
2019 | -0.54 CAD | 47.57% |
2018 | -1.03 CAD | -1309.03% |
2017 | -0.07 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.10 CAD | 31.5% |
2024 Q1 | -0.14 CAD | -16.67% |
2023 Q4 | -0.12 CAD | -30.43% |
2023 FY | - CAD | -144.44% |
2023 Q3 | -0.09 CAD | 23.33% |
2023 Q2 | -0.12 CAD | -23.2% |
2023 Q1 | -0.10 CAD | -26.33% |
2022 Q2 | -0.11 CAD | 26.67% |
2022 Q1 | -0.15 CAD | -7.14% |
2022 FY | - CAD | 68.42% |
2022 Q4 | -0.08 CAD | 40.69% |
2022 Q3 | -0.13 CAD | -18.18% |
2021 Q1 | -0.26 CAD | 10.34% |
2021 Q2 | -0.16 CAD | 38.46% |
2021 Q3 | -0.23 CAD | -43.75% |
2021 Q4 | -0.14 CAD | 39.13% |
2021 FY | - CAD | 17.39% |
2020 FY | - CAD | -27.78% |
2020 Q4 | -0.29 CAD | -123.08% |
2020 Q3 | -0.13 CAD | 0.0% |
2020 Q2 | -0.13 CAD | -18.18% |
2020 Q1 | -0.11 CAD | -17.9% |
2019 Q1 | -0.14 CAD | 50.0% |
2019 FY | - CAD | 47.57% |
2019 Q2 | -0.14 CAD | 0.0% |
2019 Q4 | -0.09 CAD | 28.23% |
2019 Q3 | -0.13 CAD | 7.14% |
2018 Q4 | -0.28 CAD | -27.27% |
2018 Q1 | -0.02 CAD | 6.18% |
2018 FY | - CAD | -1309.03% |
2018 Q2 | -0.06 CAD | -146.09% |
2018 Q3 | -0.22 CAD | -267.89% |
2017 Q4 | -0.03 CAD | -9.75% |
2017 Q2 | -0.03 CAD | 0.0% |
2017 Q3 | -0.02 CAD | 30.38% |
2017 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aurora Cannabis Inc. | -1.60 CAD | 72.5% |
Avicanna Inc. | -0.09 CAD | -372.61% |
Avant Brands Inc. | -0.61 CAD | 27.869% |
Crescita Therapeutics Inc. | -0.10 CAD | -348.98% |
Knight Therapeutics Inc. | -0.16 CAD | -175.0% |
MediPharm Labs Corp. | -0.04 CAD | -1122.222% |
OrganiGram Holdings Inc. | -2.82 CAD | 84.397% |
Canopy Growth Corporation | -8.79 CAD | 94.994% |
Willow Biosciences Inc. | -0.10 CAD | -340.0% |
Auxly Cannabis Group Inc. | -0.04 CAD | -879.955% |